These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. Mittal A; Bhatnagar S; Kumar A; Lach-Trifilieff E; Wauters S; Li H; Makonchuk DY; Glass DJ; Kumar A J Cell Biol; 2010 Mar; 188(6):833-49. PubMed ID: 20308426 [TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization. Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972 [TBL] [Abstract][Full Text] [Related]
10. The TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscle. Tajrishi MM; Sato S; Shin J; Zheng TS; Burkly LC; Kumar A Biochem Biophys Res Commun; 2014 Apr; 446(4):1219-1224. PubMed ID: 24680686 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection. Han ES; Mekasha S; Ingalls RR J Reprod Immunol; 2010 Jan; 84(1):16-23. PubMed ID: 19963275 [TBL] [Abstract][Full Text] [Related]
15. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain. Brown SA; Cheng E; Williams MS; Winkles JA PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247 [TBL] [Abstract][Full Text] [Related]
16. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571 [TBL] [Abstract][Full Text] [Related]
17. Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program. Hindi SM; Mishra V; Bhatnagar S; Tajrishi MM; Ogura Y; Yan Z; Burkly LC; Zheng TS; Kumar A FASEB J; 2014 Mar; 28(3):1398-411. PubMed ID: 24327607 [TBL] [Abstract][Full Text] [Related]
18. The TWEAK-Fn14 system as a potential drug target. Wajant H Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828 [TBL] [Abstract][Full Text] [Related]
19. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis. Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367 [TBL] [Abstract][Full Text] [Related]